Compound ID | 356
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Klebsiella pneumoniae, Proteus mirabilis and Pseudomonas aeruginosa |
| Institute where first reported: | Meiji Seika Kaisha (Meiji Seika Pharma., Japan) |
| Year first mentioned: | 1987 |
| Highest development stage: | Phase 2 |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9577434 |
| Guide to Pharmacology: | ME-1228 acid |
| Citations: |
|